Drug General Information
Drug ID	D0PC9R
Former ID	DNCL003581
Drug Name	GSK2941266
Synonyms	GSK-2941266
Indication	Rheumatoid arthritis [ICD9: 710-719, 714; ICD10:M05-M06]		Phase 2	[548754]
Company	GlaxoSmithKline
Structure		Download 2D MOL 3D MOL
Target and Pathway
Target(s)	C-C chemokine receptor type 1	Target Info	Modulator	[531908]
KEGG Pathway	Cytokine-cytokine receptor interaction
	Chemokine signaling pathway
NetPath Pathway	IL5 Signaling Pathway
	TCR Signaling Pathway
	IL2 Signaling Pathway
	TNFalpha Signaling Pathway
	Leptin Signaling Pathway
PANTHER Pathway	Inflammation mediated by chemokine and cytokine signaling pathway
Reactome	Chemokine receptors bind chemokines
	G alpha (i) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Peptide GPCRs
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 548754	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028338)
Ref 531908	Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial. Ann Rheum Dis. 2013 Mar;72(3):337-44.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.